PetMed Express Analyst Ratings
PetMed Express Analyst Ratings
| Date | Upside/Downside | Analyst Firm | Price Target Change | Rating Change | Previous / Current Rating |
|---|---|---|---|---|---|
| 11/08/2022 | -15.77% | Morgan Stanley | $19 → $18 | Maintains | Underweight |
| 07/26/2022 | -11.09% | Morgan Stanley | $20 → $19 | Maintains | Underweight |
| 05/10/2022 | -6.41% | Morgan Stanley | $21 → $20 | Maintains | Underweight |
| 01/25/2022 | -1.73% | Morgan Stanley | $25 → $21 | Maintains | Underweight |
| 01/20/2022 | 49.74% | Sidoti & Co. | → $32 | Upgrades | Neutral → Buy |
| 11/18/2021 | 16.99% | Morgan Stanley | → $25 | Initiates Coverage On | → Underweight |
| 10/01/2021 | 31.02% | Jefferies | → $28 | Initiates Coverage On | → Hold |
| 06/03/2021 | 82.5% | Sidoti & Co. | → $39 | Downgrades | Buy → Neutral |
| 03/05/2021 | — | Sidoti & Co. | Upgrades | Neutral → Buy | |
| 08/19/2020 | 91.86% | Sidoti & Co. | $37 → $41 | Upgrades | Neutral → Buy |
| 02/24/2020 | — | Sidoti & Co. | Downgrades | Buy → Neutral | |
| 10/17/2019 | -6.41% | Craig-Hallum | $15 → $20 | Maintains | Hold |
| 08/16/2019 | — | Craig-Hallum | Downgrades | Buy → Hold | |
| 07/09/2018 | — | Craig-Hallum | Downgrades | Hold → Sell | |
| 06/15/2018 | — | CL King | Initiates Coverage On | → Neutral |
| 日期 | 上行/下行 | 分析公司 | 目標價格變動 | 評級變動 | 之前/當前的評級 |
|---|---|---|---|---|---|
| 2022 年 8 月 11 日 | -15.77% | 摩根士丹利 | 19 美元 → 18 美元 | 維護 | 體重不足 |
| 07/26/2022 | -11.09% | 摩根士丹利 | 20 美元 → 19 美元 | 維護 | 體重不足 |
| 05/10/2022 | -6.41% | 摩根士丹利 | 21 美元 → 20 美元 | 維護 | 體重不足 |
| 01/25/2022 | -1.73% | 摩根士丹利 | 25 美元 → 21 美元 | 維護 | 體重不足 |
| 01/20/2022 | 49.74% | Sidoti & Co. | → 32 美元 | 升級 | 中性 → 買入 |
| 11/18/2021 | 16.99% | 摩根士丹利 | → 25 美元 | 啓動覆蓋範圍開啓 | → 體重不足 |
| 10/01/2021 | 31.02% | 傑富瑞集團 | → 28 美元 | 啓動覆蓋範圍開啓 | → 按住 |
| 06/03/2021 | 82.5% | Sidoti & Co. | → 39 美元 | 降級 | 買入 → 中性 |
| 03/05/2021 | — | Sidoti & Co. | 升級 | 中性 → 買入 | |
| 2020 年 8 月 19 日 | 91.86% | Sidoti & Co. | 37 美元 → 41 美元 | 升級 | 中性 → 買入 |
| 2020 年 2 月 24 日 | — | Sidoti & Co. | 降級 | 買入 → 中性 | |
| 10/17/2019 | -6.41% | Craig-Hallum | 15 美元 → 20 美元 | 維護 | 保持 |
| 2019 年 8 月 16 日 | — | Craig-Hallum | 降級 | 買入 → 持有 | |
| 2018 年 9 月 7 日 | — | Craig-Hallum | 降級 | 持有 → 賣出 | |
| 06/15/2018 | — | CL King | 啓動覆蓋範圍開啓 | → 中立 |
PetMed Express Questions & Answers
PetMed Express 問答
The latest price target for PetMed Express (NASDAQ: PETS) was reported by Morgan Stanley on November 8, 2022. The analyst firm set a price target for $18.00 expecting PETS to fall to within 12 months (a possible -15.77% downside). 6 analyst firms have reported ratings in the last year.
摩根士丹利於2022年11月8日公佈了PetMed Express（納斯達克股票代碼：PETS）的最新目標股價。該分析公司將目標股價定爲18.00美元，預計PETS將在12個月內降至-15.77％（可能下跌15.77％）。去年有6家分析公司公佈了評級。
The latest analyst rating for PetMed Express (NASDAQ: PETS) was provided by Morgan Stanley, and PetMed Express maintained their underweight rating.
摩根士丹利提供了PetMed Express（納斯達克股票代碼：PETS）的最新分析師評級，PetMed Express維持其減持評級。
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of PetMed Express, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for PetMed Express was filed on November 8, 2022 so you should expect the next rating to be made available sometime around November 8, 2023.
分析師在進行了廣泛的研究後得出了股票評級，其中包括瀏覽公開財務報表，與PetMed Express的高管和客戶交談，以及聽取業績電話會議。大多數分析師每三個月做一次這樣的評級，因此每家公司每年應該獲得4次評級。PetMed Express的最新評級是在2022年11月8日公佈的，因此您應該預計下一個評級將在2023年11月8日左右公佈。
While ratings are subjective and will change, the latest PetMed Express (PETS) rating was a maintained with a price target of $19.00 to $18.00. The current price PetMed Express (PETS) is trading at is $21.37, which is out of the analyst's predicted range.
儘管評級是主觀的，並且會發生變化，但最新的PetMed Express（PETS）評級保持不變，目標股價爲19.00美元至18.00美元。PetMed Express（PETS）目前的交易價格爲21.37美元，超出了分析師的預期區間。